Image-guided therapy
transparent video

Image-guided therapy

Philips is the leader in image-guided therapy, providing integrated solutions that advance minimally invasive procedures. We help healthcare providers to decide, guide, treat and confirm the right care in real time during the procedure to enable better outcomes for each patient and at population level.

 

Working together with clinicians, we use our comprehensive portfolio of interventional imaging systems, smart devices, software and services to treat one patient every second worldwide.

 

Together with health providers we optimize care delivery, reduce total costs, and help clinicians treat patients better so they can get back faster to the lives they love.

Image guided intervention

Experience our portfolio

Image Guided Therapy news and blogs

The next leap in lab integration

As your practice evolves to treat more patients and perform more complex procedures, how do you make sound judgments in an ever more crowded and fragmented environment? Now you can control all relevant applications for diverse interventional procedures from one touch screen module at table side, to help make fast, informed decisions without breaking sterility. All aimed to ultimately improve the quality and efficiency of your procedures. With Azurion, performance and superior care become one.

Future of IGT promo video

Clinical proof

The ability to treat one more patient per day today, or in the future

 

This is just one of the many improvements in lab performance achieved by the Interventional Vascular Department at St. Antonius Hospital after installing the Philips Azurion system. This first Azurion lab performance study achieved impressive results which have been verified by an independent third party.

St. Antonius Hospital Azurion

iFR Outcome Data

 

New data from the DEFINE FLAIR study was presented during a late-breaking session at ACC 2018. These results show that an iFR-guided strategy is more cost effective than an FFR-guided strategy, with a 10% cost reduction per patient resulting in an average savings of $896 through 1-year follow-up.¹

iFR Outcome data
Let's talk #futureofIGT #azurion

Let’s talk  

#futureofIGT #azurion

 

How would you improve interventional procedures? What do you think about the Azurion? Are we on the right track? Connect with us via #futureofIGT / #azurion

*

Contact information

* This field is mandatory

*
*
*
*
*
*
*
*
*

By specifying your reason for contact we will be able to provide you with a better service.

We work with partners and distributors who may contact you about this Philips product on our behalf.

*
*

Philips values and respects the personal information of its customers. You may revoke the permissions you grant at any time. See the Philips Privacy Policy for more information.

Disclaimers

  1. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.  

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

Ви заходите на сайт Philips Healthcare
Please select the checkbox

Веб-сайт призначений лише для лікарів та медичних працівників, які використовують медичне обладнання в своїй професійній діяльності; осіб, які працюють в сфері організації охорони здоров’я або які реалізовують медичне обладнання.

Ви належите до вищезазначених категорій осіб?